Overall rank by patents
#5,397
Across all tracked assignees
USPTO PatentsView assignee record - 64 granted patents across 42 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: Y02E (REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION).
The verdict
Senvion holds 64 US patents across 42 technology areas, rank #5,397 of 50,000 tracked assignees.
Senvion SE has been granted 64 US utility patents between 2015 and 2019, placing Senvion SE at rank #5,397 across all assignees tracked by PlainPatent. This portfolio spans 42 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.7 claims per patent with primary concentration in Y02E (REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION). As a Foreign Corporation, Senvion SE is one of the more focused assignees in the PatentsView dataset. By volume, Senvion sits between Paul Scherrer Institut (64 patents, rank #5,393) and Sanctuary Cognitive Systems Corporation (64 patents, rank #5,401) - the closest US assignees by grant volume. The composite Innovation Score of 46.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 64 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Senvion SE's 15.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 42 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Senvion SE against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Paul Scherrer Institut
64 patents
Penumbra, Inc.
64 patents
RAKUTEN KOBO INC.
64 patents
Rubbermaid Incorporated
64 patents
SHENZHEN ZHENGTU AUTO ACCESSORIES CO., LTD.
64 patents
SIO2 MEDICAL PRODUCTS, LLC
64 patents
Sakai Chemical Industry Co., Ltd.
64 patents
Sanctuary Cognitive Systems Corporation
64 patents
SENVION SE
64 patents
What this shows Senvion holds 64 patents at rank #5,397, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,397 in granted patent volume.
Other assignees with the most granted patents in Senvion's primary technology class.
Senvion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 20% higher than 80% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 18 | 28.1% |
| 2016 | 13 | 20.3% |
| 2017 | 18 | 28.1% |
| 2018 | 10 | 15.6% |
| 2019 | 5 | 7.8% |
Top 15 of 42 technology areas
Overall rank by patents
#5,397
Across all tracked assignees
46.7 out of 100
How to use this portfolio
Senvion's 64 grants land it in the top 20% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.